Apollo Hospitals share price gains 2% as Morgan Stanley retains overweight call

The research firm is of the view that COVID-19 has paused its growth trajectory. However, volume recovery, cost rationalisation and asset monetisation should keep B/S healthy.

Read Full Story on MoneyControl

Enter your email address:


We will be happy to hear your thoughts

      Leave a reply

      IndiaClicking - Buzzing News & Stocks